Therapeutics and Global Markets" report has been added to ResearchAndMarkets.com's offering.The global market for mRNA therapeutics was valued at $7.71 billion in 2025 and is forecast to remain stable ...

The UC Santa Cruz RNA Center hosted a premiere screening of “Cracking the Code: Phil Sharp and the Biotech Revolution” at the ...

MRNA acts as the key intermediate between DNA, the genetic blueprint, and proteins that carry out most of the work in cells, with RNA splicing ensuring proper reading of the blueprint by removing some ...

Circulating tumor DNA (ctDNA) is a promising biomarker for monitoring treatment response and progression-free survival in ...

E. John Wherry, director of Penn's Colton Center for Autoimmunity, spoke with the Inquirer about the future of immunology ...

Your letters and WhatsApps to the editor ...

Biotech clinical laboratories are at the center of new medical discoveries, using tools like molecular biology and genetics ...

Further validating the results, University of Florida researchers found that tying cancer immunotherapies with COVID-targeted ...

Scientists from CNRS have developed new stable and effective messenger RNA (mRNA) sequences that enable cells to produce therapeutic proteins themselves, capable of inducing antibody ...

A new study suggests that mRNA vaccines for COVID-19 could help boost the effects of immunotherapy drugs for some cancer patients.

Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic ...

In a discovery that ties the biology of aging to cancer risk, scientists from the University of Tokyo have found that the ...